ASTM Subcommittee on Cell Signaling (F04.46) Established May 2006 Anne Plant, NIST Norfolk VA May 24, 2007.

Slides:



Advertisements
Similar presentations
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Advertisements

Management Quality - Achieving Excellence in Allied Health Profession’s Services Management Quality Matrix Dr Robert Jones Head of Therapy Services Directorate.
Donald T. Simeon Caribbean Health Research Council
Lessons Learned from Measuring Cell Response by Quantitative Automated Microscopy FDA Workshop, Potency Measurements for Cellular and Gene Therapy Products,
Task Force on National Greenhouse Gas Inventories Tier 3 Approaches, Complex Models or Direct Measurements, in Greenhouse Gas Inventories Report of the.
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
School of something FACULTY OF OTHER Institute for Transport Studies FACULTY OF ENVIRONMENT Evaluating cohesion by a MCA framework : application at a TEN-T.
Combining Product Risk Management & Design Controls
Special Topics in IND Regulation
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Guidance for Industry Establishing Pregnancy Registries Pregnancy Registry Working Group Pregnancy Labeling Taskforce March, 2000 Evelyn M. Rodriguez M.D.,
What should be the basis of
Research & Innovation Horizon societal challenge 1 Open Info Day Funding Opportunities for SMEs Horizon 2020 "Health, demographic change and wellbeing"
Thoughts on Biomarker Discovery and Validation Karla Ballman, Ph.D. Division of Biostatistics October 29, 2007.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Contemporary Nursing Practice Chapter 1 Overview.
SOAR – Preparing for Launch Author Information January 2015.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Advanced Cancer Topics Journal Review 4/16/2009 AD.
„International Research Project on Financing Quality in Health Care” InterQuality WP 2 Values/Benefits (development of methodology for cost and outcome.
HD 2007 Rule Diesel Fuel Sulfur Testing and Sampling Methods and Requirements US EPA Office of Transportation and Air Quality November 20, 2002.
Data Analysis Summary. Elephant in the room General Comments General understanding that informatics is integral in medical sequencing and other –omics.
Understanding cell state with quantitative live cell imaging Copyright © 2000 Cell Press. The Hallmarks of Cancer Douglas Hanahan and Robert A. Weinberg.
The SNM Centralized IND & Clinical Trials Network Enabling Implementation Investigational & Approved PET Imaging in Multicenter Clinical Trials George.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
North East Drive Mobility Pathway Development Forum of Mobility Centres Open Meeting 8 June 2011.
Presenter’s Name June 17, Directions for this Template  Use the Slide Master to make universal changes to the presentation, including inserting.
Use of live cell microscopy to follow the temporal regulation of gene expression October 6 th, 2009 Michael Halter, Joe Chalfoun, Antonio Cardone, Benjamin.
EN ISO 18104:2003 Integration of a reference terminology model for nursing – Review proposal Anne Casey RN MSc FRCN Editor, Paediatric Nursing Adviser.
Cancer Stem Cells: Some statistical issues  What you would like to do: Identify ways to design studies with increased statistical “power” in clinical.
Mats Wallin Swedish Univ. of Agricultural Sciences Dept. of Environmental Assessment Catarina Johansson Swedish Environmental Protection Agency Development.
COMPARABILITY PROTOCOLUPDATE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE Manufacturing Subcommittee July 20-21, 2004 Stephen Moore, Ph.D. Chemistry Team.
1 The United Nations Demographic Yearbook and the Work Programme for Social Statistics Expert Group Meeting to Review the United Nations Demographic Yearbook.
Cris Ross, co-chair Anita Somplasky, co-chair December 1, 2015 Certified Technology Comparison (CTC) Task Force.
Bacterial Biofilms as a Complex Community Tracy K. Teal D. K. Newman and B. J. Wold Labs Complexity Club August 13, 2003.
Conceptual Site Models Purpose, Development, Content and Application CP Annual Training October 27, 2015.
Laboratory Perspective on Testing Methodologies Wendy Warren-Serna, Ph.D. USDA-FSIS Public Meeting Control of E. coli O157:H7.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
Development of Toxicity Indicators Steven Bay Southern California Coastal Water Research Project (SCCWRP)
Network applications Sushmita Roy BMI/CS 576 Dec 9 th, 2014.
PREPARED BY The New Zealand Cancer Nurse Coordinator Initiative Natalie James National Nurse Lead May 2013.
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 8 Planning and Outcome Identification.
NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.
Identification of Cancer Stem Cells using Flow Cytometry Analysis تعيين الخلايا الجذعية السرطانية باستخدام تحليل التدفق الخلوي Dr. Ayat Al-Ghafari Biochemistry.
Coming Soon – the MRC Framework for the Development, Design and Analysis of Stratified Medicine Research Dr David Crosby MRC Programme Manager for Methodology.
In the name of God. Common Technical Document On Biotech.
Chapter 8 Outcome Identification and Planning Fundamentals of Nursing: Standards & Practices, 2E.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 47 Activities of Daily Living and Instrumental Activities of Daily Living.
Building an Evidence-Based Nursing Practice
SNOMED CT Education SIG: Strategic Plan Review
Evidence-based Medicine
Cell Delivery Mechanisms for Tissue Repair
Statistical Approaches to Support Device Innovation- FDA View
Monitoring and Evaluation Systems for NARS Organisations in Papua New Guinea Day 2. Session 6. Developing indicators.
The Manager as a Planner and Strategist
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
MIS5101 Week 3: Data-Driven Management
Biomedical Research.
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
CIS guidance document on E-Flows
Evaluation and Management of End-Stage Liver Disease in Children
Hallmarks of Cancer: The Next Generation
Unit I Module 3 - RCM Terminology and Concepts
Cell Delivery Mechanisms for Tissue Repair
Lino Ferreira, Jeffrey M. Karp, Luis Nobre, Robert Langer 
The Hallmarks of Cancer
TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease
Stat4Onco Annual Symposium Zhenming Shun April 27, 2019
DRAFT ISO 10007:2017 Revision Overview Quality management – Guidelines for configuration management ISO/TC176 TG 01.
Directions for this Template
Vylyny Chat, Robert Ferguson, Tomas Kirchhoff 
Presentation transcript:

ASTM Subcommittee on Cell Signaling (F04.46) Established May 2006 Anne Plant, NIST Norfolk VA May 24, 2007

TE products depend on achieving desired response of cells Cell response is complicated: many parameters, largely undefined Cells are extremely sensitive to their environment (ECM, scaffold, in vivo conditions) WHY Standards for Cell Signaling? Copyright © 2000 Cell Press. The Hallmarks of Cancer Douglas Hanahan and Robert A. Weinberg

Purpose of the Subcommittee on Cell Signaling Directing cells to migrate, differentiate, and assemble in a desired fashion may require understanding of the intracellular pathways that control the response of cells to a complex environment. Accurate and quantitative measurements of cell signaling biomarkers, aided by reference materials and standards would aid R&D (development of hypotheses, prediction of outcome, comparison of data over time). Would aid regulatory, and QA/QC (by providing predictive capabilities for determining safety, efficacy). More than one biomarker may be needed to evaluate a response. Standardized assays would facilitate pooling of data.

Stages of product development R&D: Must have quantitative methods for comparing cells day to day to evaluate differentiation, response to conditions and materials QA/QC: Must have quantitative methods to evaluate health of cells, predict future response, determine consistency WHY Standards for Cell Signaling?

: Classification of Signaling Pathways Ex: kinases, integrin-dependent, G-protein coupled, mechanical response, differentiation, etc. Cell Signaling Mechanism-Based assays for Cytotoxicity Greater predictive capability compared to live/dead Terminology and Definitions (Horowitz) Standard Protocols for Extracellular Matrix Preparation and Presentation Expected response from cells under controlled conditions Stable Storage of Cells Integrity wrt genetics, response to environment, ‘health’. Cell Identification markers Standard conditions, cell normalization, defined media Quantitative methods for comparison of cells (Elliott) Task areas previously under consideration: Some of these topics may be well-developed, some may be research areas. Comments? Topics in RED were added during Atlanta meeting spring 2006

Cell morphology and optical ‘mask’ for quantifying intracellular markers [Elliott] Statistical analysis for cell population distributions Quantification of GFP in reporter cells Cell volume as an indicator of growth rate, division time Underpinning protocols: Quantitative methods for comparison of cells

Goals for this Subcommittee meeting 1.Report on draft guidance document on protocol for measuring morphology John Elliott, NIST 2.Report on terminology Manny Horowitz, Johns Hopkins University 3.Populate task groups

Classification of Signaling Pathways (and associated informatics) Cell Signaling Mechanism-Based assays for Cytotoxicity Stress (Moos, Kaplan, Durfor, Doser, Williams) Terminology and Definitions (Horowitz) Standard Protocols for Extracellular Matrix Preparation and Presentation for controlling signaling (Lee, Durfor, Kaplan, Elliott) Cell Identification markers (Moos) Stable Storage of Cells (Suh) Standard conditions, defined media (Suh) Quantitative methods for comparison of cells (Elliott) Criteria for biomarker validation (measurement, clinical relevance, multiple markers) (McFarland, Moos, Elliott) Matrix remodeling Cell Proliferation Updated Task Areas: Standards, protocols or guidance for… Updated Norfolk, 5/24/07. Changes to previous list are in red (added) or grey (deleted). Task force contributors are in parentheses.

Other discussion topics that arose: Using documents from other organizations such as AATB; and encouraging individuals from such organizations to participate in ASTM (Suh) [Additional input welcome] Tumorogenicity (this might be incorporated into the ‘Stress’ topic) (Durfor) Symposium on Cell Signaling Measurements (follow-up to 2003 symposium). To be held at NIST? Sometime in 2008? (Horowitz, Elliott) [Additional input welcome] Your input is critical! All task areas are open to anyone who is interested in participating. Next meeting is during ASTM meeting week November 13-16, Tampa FL